Sarepta Therapeutics, Inc. — Director's Dealing 2011

Jun 22, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVI BIOPHARMA INC (AVII)
CIK: 0000873303
Period of Report: 2011-06-21

Reporting Person: Goolsbee William Alden (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-06-21	Common Stock	A	5000	—	Acquired	20000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-21	Stock Option (right to buy)	$1.41	A	30000	Acquired	2021-06-21	Common Stock (30000)	Direct

Footnotes

F1: Grant of restricted stock which vests on the earlier of (a) the anniversary date of the grant and (b) the date of the 2012 annual meeting of shareholders.

F2: This option will vest on the earlier of (a) the anniversary date of the grant and (b) the date of the 2012 annual meeting of shareholders.